Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C024566 |
1,1,1-trichloroethane |
1,1,1-trichloroethane results in decreased activity of [GRIN1 protein binds to GRIN2A protein] | affects binding|decreases activity | 11090101
|
C076996 |
27-hydroxycholesterol |
27-hydroxycholesterol results in decreased phosphorylation of GRIN2A protein | decreases phosphorylation | 18503570
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of GRIN2A mRNA | increases expression | 18648102
|
C498554 |
5-(alpha-methyl-4-bromobenzylamino)phosphonomethyl-1,4-dihydroquinoxaline-2,3-dione |
5-(alpha-methyl-4-bromobenzylamino)phosphonomethyl-1,4-dihydroquinoxaline-2,3-dione results in decreased activity of GRIN2A protein | decreases activity | 16822975
|
D000493 |
Allopurinol |
Allopurinol inhibits the reaction [ammonium acetate results in decreased expression of GRIN2A protein] | decreases expression|decreases reaction | 20084674
|
C018824 |
ammonium acetate |
Allopurinol inhibits the reaction [ammonium acetate results in decreased expression of GRIN2A protein] | decreases expression|decreases reaction | 20084674
|
C018824 |
ammonium acetate |
ammonium acetate results in decreased expression of GRIN2A protein | decreases expression | 20084674
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GRIN2A mRNA | affects expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the localization of GRIN2A protein | affects localization | 16678351
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in decreased expression of GRIN2A protein | decreases expression | 16483693
|
D001554 |
Benzene |
Benzene results in decreased activity of [GRIN1 protein binds to GRIN2A protein] | affects binding|decreases activity | 11090101
|
D004390 |
Chlorpyrifos |
Chlorpyrifos affects the expression of GRIN2A mRNA | affects expression | 19440498 17452286
|
D003024 |
Clozapine |
Clozapine results in decreased expression of GRIN2A mRNA | decreases expression | 12608697 18923069
|
D003975 |
Diazepam |
GRIN2A protein affects the susceptibility to Diazepam | affects response to substance | 15731593
|
D003976 |
Diazinon |
Diazinon affects the expression of GRIN2A mRNA | affects expression | 19440498
|
D003976 |
Diazinon |
Diazinon results in increased expression of GRIN2A mRNA | increases expression | 17452286
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased phosphorylation of GRIN2A protein | decreases phosphorylation | 18503570
|
D016291 |
Dizocilpine Maleate |
Dizocilpine Maleate results in increased phosphorylation of GRIN2A protein | increases phosphorylation | 11249956
|
D004958 |
Estradiol |
Estradiol results in decreased expression of GRIN2A mRNA | decreases expression | 20068009
|
C004912 |
ethylbenzene |
ethylbenzene results in decreased activity of [GRIN1 protein binds to GRIN2A protein] | affects binding|decreases activity | 11090101
|
D018690 |
Excitatory Amino Acid Agonists |
Excitatory Amino Acid Agonists binds to and results in increased activity of [GRIN1 protein binds to GRIN2A protein] | affects binding|increases activity | 11812690
|
D018690 |
Excitatory Amino Acid Agonists |
Urethane inhibits the reaction [Excitatory Amino Acid Agonists binds to and results in increased activity of [GRIN1 protein binds to GRIN2A protein]] | affects binding|decreases reaction|increases activity | 11812690
|
D006220 |
Haloperidol |
Haloperidol results in decreased expression of GRIN2A mRNA | decreases expression | 15860345 12608697
|
D007649 |
Ketamine |
GRIN2A protein affects the susceptibility to Ketamine | affects response to substance | 15731593
|
D008874 |
Midazolam |
GRIN2A protein affects the susceptibility to Midazolam | affects response to substance | 15731593
|
D008911 |
Minocycline |
Minocycline inhibits the reaction [Poly C results in increased expression of GRIN2A mRNA] | decreases reaction|increases expression | 19660546
|
D009609 |
Nitrous Oxide |
GRIN2A protein affects the susceptibility to [Nitrous Oxide co-treated with sevoflurane] | affects cotreatment|affects response to substance | 15731593
|
C024268 |
n-propylbenzene |
n-propylbenzene results in decreased activity of [GRIN1 protein binds to GRIN2A protein] | affects binding|decreases activity | 11090101
|
D010424 |
Pentobarbital |
GRIN2A protein affects the susceptibility to Pentobarbital | affects response to substance | 15731593
|
D010424 |
Pentobarbital |
Pentobarbital affects the expression of GRIN2A mRNA | affects expression | 9814547
|
D010862 |
Pilocarpine |
Pilocarpine results in decreased expression of GRIN2A protein | decreases expression | 15857427
|
D011066 |
Poly C |
Minocycline inhibits the reaction [Poly C results in increased expression of GRIN2A mRNA] | decreases reaction|increases expression | 19660546
|
D011066 |
Poly C |
Poly C results in increased expression of GRIN2A mRNA | increases expression | 19660546
|
D015742 |
Propofol |
GRIN2A protein affects the susceptibility to Propofol | affects response to substance | 15731593
|
C009250 |
sevoflurane |
GRIN2A protein affects the susceptibility to [Nitrous Oxide co-treated with sevoflurane] | affects cotreatment|affects response to substance | 15731593
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of GRIN2A mRNA | decreases expression | 19041379
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of GRIN2A mRNA | increases expression | 16839606 11742229
|
D014050 |
Toluene |
Toluene results in increased expression of GRIN2A mRNA | increases expression | 17870172
|
D014050 |
Toluene |
Toluene results in increased expression of GRIN2A protein | increases expression | 15695158
|
D014050 |
Toluene |
Toluene results in decreased activity of [GRIN1 protein binds to GRIN2A protein] | affects binding|decreases activity | 9655877
|
D014520 |
Urethane |
Urethane inhibits the reaction [Excitatory Amino Acid Agonists binds to and results in increased activity of [GRIN1 protein binds to GRIN2A protein]] | affects binding|decreases reaction|increases activity | 11812690
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of GRIN2A protein | increases expression | 17675408
|
D014992 |
Xylenes |
Xylenes results in decreased activity of [GRIN1 protein binds to GRIN2A protein] | affects binding|decreases activity | 11090101
|
D015032 |
Zinc |
Zinc results in decreased activity of GRIN2A protein | decreases activity | 16822975
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.14 | 14514962 15322242 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
7.14 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.61 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.21 | 18287403 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
5.05 | 16889938 17190629 17202136 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.45 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Urethane |
4.45 | 18316556 |
MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Urethane |
5.35 | 15814487 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.40 | 3712494 |
MESH:D000236 |
Adenoma |
|
Urethane |
6.40 | 17093202 10822126 17195641 16926031 10530776 6695378 11497255 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.34 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.54 | 16712894 17306315 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.71 | 14617031 16160616 12649775 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Chlorpyrifos |
8.00 | 11874814 16611668 17119214 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Diazinon |
8.00 | 16487989 |
MESH:D000544 |
Alzheimer Disease |
|
27-hydroxycholesterol |
4.63 | 20157255 14523054 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
4.63 | 16325427 16410023 17119284 16580781 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.87 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.64 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
4.10 | 17661222 14761424 11369114 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.56 | 16916123 |
MESH:D001008 |
Anxiety Disorders |
|
Diazepam |
13.55 | 16284244 18313124 |
MESH:D001008 |
Anxiety Disorders |
|
Pentobarbital |
13.55 | 18313124 11141031 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
13.55 | 17497229 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Xylenes |
5.23 | 513065 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.54 | 15238619 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Minocycline |
4.14 | 14528503 |
MESH:D001249 |
Asthma |
|
Zinc |
2.84 | 17085522 |
MESH:D050197 |
Atherosclerosis |
|
27-hydroxycholesterol |
4.22 | 9059518 11166758 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 15830322 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.34 | 19368416 18080171 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.34 | 18396377 15238991 18940202 18985861 19460635 20603192 16609825 18316065 19232924 18558336 17157402 17507914 18177632 18775368 17688650 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.66 | 1440618 11289319 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.89 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.73 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.43 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.26 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.26 | 8888407 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.87 | 16183116 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
4.34 | 17109824 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
1.91 | 11921183 17162533 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
1.91 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.91 | 19861407 12948864 17018787 17289903 16675129 17261762 14630087 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.91 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.11 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.52 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
4.23 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.23 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
4.23 | 16507464 17306315 15276417 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.51 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.54 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
4.54 | 16543248 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.17 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
3.42 | 16936243 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
4.56 | 1977408 15215559 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
9.79 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
9.79 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
9.79 | 20056578 19524636 |
MESH:D002547 |
Cerebral Palsy |
|
Toluene |
5.49 | 9294310 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.58 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.87 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
2.89 | 19486331 9022650 |
MESH:D002972 |
Cleft Palate |
|
Diazepam |
9.25 | 3629520 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
9.25 | 8697196 12621046 15340226 15668235 16354765 |
MESH:D002972 |
Cleft Palate |
|
Urethane |
9.25 | 12810352 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.62 | 17123785 |
MESH:D015179 |
Colorectal Neoplasms |
marker/mechanism |
|
| 17922030 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.76 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
6.88 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
6.88 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Toluene |
6.88 | 9294310 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
6.88 | 8888407 17688650 16575769 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
6.88 | 19302082 |
MESH:D003643 |
Death |
|
Toluene |
5.31 | 6431079 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
4.52 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.26 | 11575062 |
MESH:D003715 |
Dengue |
|
27-hydroxycholesterol |
5.33 | 19427377 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.42 | 15902427 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.48 | 12868966 11298694 18759878 2524372 8156756 14531868 8970840 11906362 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.17 | 2952479 3621924 |
MESH:D017453 |
Dermatitis, Irritant |
|
Xylenes |
6.48 | 17574719 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
3.91 | 16479319 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
4.19 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.19 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.12 | 19279558 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.19 | 15331141 |
MESH:D004283 |
Dog Diseases |
|
Allopurinol |
5.90 | 10449224 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
1,1,1-trichloroethane |
8.15 | 6623471 2862719 4356632 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
8.15 | 1440618 9022650 9328219 18289764 7440962 18692083 9653073 6679447 8291058 16192314 18648102 11289319 6482804 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.15 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
8.15 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.50 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
8.02 | 16402076 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
8.02 | 18367378 |
MESH:D004417 |
Dyspnea |
|
Diazinon |
4.44 | 16487989 |
MESH:D004421 |
Dystonia |
|
Diazepam |
9.96 | 1851702 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
9.96 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.08 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.54 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
27-hydroxycholesterol |
9.31 | 17410599 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Minocycline |
9.31 | 11835378 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.75 | 18566989 11473722 19148513 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.72 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.81 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Diazepam |
9.39 | 3922381 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
9.39 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
marker/mechanism |
|
| 20890276 |
MESH:D004827 |
Epilepsy |
|
Diazepam |
10.40 | 821787 |
MESH:D004827 |
Epilepsy |
|
Pilocarpine |
10.40 | 11162239 19700373 19439326 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
10.40 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Diazepam |
8.49 | 6401628 6426943 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
8.49 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
3.95 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.71 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.34 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
4.34 | 16543248 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.75 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
6.86 | 19551842 17967931 19004024 18296743 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
6.86 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.11 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.53 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.79 | 8888407 18558336 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.66 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
7.48 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.48 | 20067830 |
MESH:D005600 |
Fragile X Syndrome |
|
Minocycline |
6.40 | 18835858 |
MESH:D005756 |
Gastritis |
|
Zinc |
4.44 | 17241300 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.32 | 16452187 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.71 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.23 | 10696789 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
3.73 | 17217573 |
MESH:D006261 |
Headache |
|
Ketamine |
5.65 | 11554966 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.14 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Urethane |
4.00 | 16046796 |
MESH:D006333 |
Heart Failure |
|
Zinc |
3.39 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
5.41 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
4.21 | 17241300 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.33 | 16183116 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.02 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
8.47 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Diazinon |
8.47 | 16487989 |
MESH:D006521 |
Hepatitis, Chronic |
|
1,1,1-trichloroethane |
11.62 | 12594376 |
MESH:D006521 |
Hepatitis, Chronic |
|
Minocycline |
11.62 | 14986274 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
4.34 | 17276780 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.55 | 12621046 15340226 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.67 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.87 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.39 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.51 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.68 | 8697196 16354765 15340226 18606429 16959395 |
MESH:D006937 |
Hypercholesterolemia |
|
27-hydroxycholesterol |
8.59 | 17873880 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
8.59 | 21332399 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
4.56 | 16046005 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.29 | 21332399 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.59 | 15034207 |
MESH:D006973 |
Hypertension |
|
Benzene |
4.84 | 17940673 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.84 | 18670907 18850075 |
MESH:D007248 |
Infertility, Male |
|
Diazinon |
6.35 | 16466525 12948887 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.35 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
4.30 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.30 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
6.60 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.60 | 16393666 16627594 |
MESH:D007511 |
Ischemia |
|
Zinc |
4.29 | 16584753 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.66 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.02 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
8.99 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
8.99 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
8.99 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
4.10 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.42 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.42 | 15610895 |
MESH:D007859 |
Learning Disorders |
|
sevoflurane |
4.43 | 19212262 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Allopurinol |
4.98 | 12207774 9314461 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Allopurinol |
4.85 | 7498017 10449224 11332679 |
MESH:D007938 |
Leukemia |
|
Benzene |
3.21 | 15935818 18335105 17119257 14694614 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
4.00 | 17506065 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
3.87 | 19478238 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.87 | 16294345 17596541 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
3.71 | 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.68 | 18296743 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.97 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
2.14 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.14 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Chlorpyrifos |
2.99 | 15991261 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
6.74 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
6.74 | 16984957 |
MESH:D008113 |
Liver Neoplasms |
|
Urethane |
6.74 | 16391232 17093202 17559639 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
8.58 | 598648 6587162 3712494 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
8.58 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
8.58 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.94 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
10.18 | 14698565 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
10.18 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
4.53 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
4.53 | 15276417 16712894 17077188 17306315 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.53 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Urethane |
4.53 | 11893704 17093202 12765245 12117781 17255336 17195641 11544531 16007126 6695378 11497255 15166089 16391232 12466968 14587096 15902970 11552296 16926031 15136453 10997738 10530776 11807781 16788158 11992545 11074608 11323394 11062179 12957351 11307925 16289808 11246140 10822126 16337739 16204055 10779650 7750092 |
MESH:D008223 |
Lymphoma |
|
Benzene |
3.49 | 17584886 17119257 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
4.09 | 12562636 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
8.80 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
8.80 | 11807958 16891317 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
8.80 | 12773700 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.12 | 19453300 |
MESH:D008545 |
Melanoma |
marker/mechanism |
|
| 21499247 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
1.98 | 16487513 19082730 |
MESH:D008569 |
Memory Disorders |
|
sevoflurane |
4.41 | 19212262 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
7.20 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
7.20 | 16856516 |
MESH:D008607 |
Mental Retardation |
|
Toluene |
3.53 | 9294310 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.12 | 19142101 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.94 | 18765137 18803445 |
MESH:D019957 |
Motor Skills Disorders |
|
Toluene |
4.91 | 9294310 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
3.42 | 17119195 |
MESH:D020529 |
Multiple Sclerosis, Relapsing-Remitting |
|
Minocycline |
6.41 | 11835378 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.71 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
2.95 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.74 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.01 | 16810080 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.32 | 3581430 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.92 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Urethane |
4.92 | 15625555 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
8.33 | 20056578 |
MESH:D009374 |
Neoplasms, Experimental |
|
Urethane |
8.33 | 15582191 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.38 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Minocycline |
5.56 | 435818 444868 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
14.62 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Pilocarpine |
14.62 | 15987249 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
14.62 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
15.45 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
15.45 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
15.45 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
15.45 | 8888407 16359493 |
MESH:D020078 |
Neurogenic Inflammation |
|
Xylenes |
5.67 | 19159661 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Chlorpyrifos |
3.93 | 15081274 |
MESH:D009765 |
Obesity |
|
Clozapine |
4.55 | 18515891 19142110 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.55 | 18674790 20518802 19632207 11836018 16723640 20132043 18457598 17217161 21332399 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
8.14 | 4026338 6482804 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
8.14 | 17119257 15612468 17479406 15935809 17178637 16737584 15576619 15727169 15913788 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.66 | 3988306 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
10.37 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.37 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
10.37 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Urethane |
10.37 | 16391232 |
MESH:D010146 |
Pain |
|
Xylenes |
4.65 | 19159661 3412491 |
MESH:D010149 |
Pain, Postoperative |
|
Ketamine |
5.76 | 11554966 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.14 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.89 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.11 | 6228378 |
MESH:D010911 |
Pituitary Neoplasms |
|
Urethane |
5.07 | 16391232 |
MESH:D011041 |
Poisoning |
|
Diazinon |
4.03 | 17603234 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.22 | 18163543 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
3.90 | 17114810 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.29 | 11896295 11222880 11399792 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
8.29 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.57 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.75 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.75 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
2.75 | 16700911 12429649 16606632 16517595 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.18 | 11422049 12752131 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
4.61 | 11575062 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
8.31 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
8.31 | 11575062 |
MESH:D011649 |
Pulmonary Alveolar Proteinosis |
|
27-hydroxycholesterol |
6.03 | 15466366 |
MESH:D012021 |
Reflex, Abnormal |
|
Pentobarbital |
5.67 | 10930210 |
MESH:D012135 |
Respiratory Sounds |
|
Chlorpyrifos |
4.29 | 16611668 17119214 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.50 | 18990726 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Chlorpyrifos |
4.53 | 16611668 17119214 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
8.14 | 3692021 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
8.14 | 16584753 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.85 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
7.53 | 20580759 17123785 18855531 16141801 20107430 18806925 20521326 19369910 11763009 20521320 17726453 20168265 20452607 11151749 17667964 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
7.53 | 19369910 18513383 20107430 1830565 |
MESH:D012559 |
Schizophrenia |
|
Ketamine |
7.53 | 20000043 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
7.53 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Diazepam |
28.97 | 15946322 10087439 9754883 |
MESH:D012640 |
Seizures |
|
Dizocilpine Maleate |
28.97 | 11218047 17157343 12660363 |
MESH:D012640 |
Seizures |
|
Midazolam |
28.97 | 10087439 |
MESH:D012640 |
Seizures |
|
Nitrous Oxide |
28.97 | 9754883 |
MESH:D012640 |
Seizures |
|
Pentobarbital |
28.97 | 10087439 9754883 |
MESH:D012640 |
Seizures |
|
Pilocarpine |
28.97 | 19660546 7750514 |
MESH:D012640 |
Seizures |
|
Toluene |
28.97 | 9294310 6431079 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
28.97 | 15475178 1511512 16876388 3137016 11738929 11044598 17978042 14763951 |
MESH:D012729 |
Sex Chromosome Aberrations |
|
Chlorpyrifos |
5.73 | 6418539 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
8.57 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.57 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Urethane |
8.57 | 11807781 |
MESH:D012893 |
Sleep Disorders |
|
Midazolam |
5.66 | 6138072 |
MESH:D007319 |
Sleep Initiation and Maintenance Disorders |
|
Midazolam |
5.44 | 6138071 |
MESH:D019082 |
Smith-Lemli-Opitz Syndrome |
|
27-hydroxycholesterol |
5.67 | 11254748 |
OMIM:270800 |
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE |
|
27-hydroxycholesterol |
6.02 | 19812052 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
8.64 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
8.64 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Pilocarpine |
11.64 | 15857427 11259499 19055492 19951488 19430551 15987249 19570321 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
11.64 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
2.41 | 12562636 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Diazepam |
15.21 | 9754883 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Nitrous Oxide |
15.21 | 9754883 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Pentobarbital |
15.21 | 9754883 11529278 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
4.37 | 20210726 |
MESH:D013733 |
Testicular Diseases |
|
Toluene |
10.09 | 10048760 10514026 |
MESH:D013733 |
Testicular Diseases |
|
Xylenes |
10.09 | 10048760 10514026 |
MESH:D013742 |
Tetanus |
|
Midazolam |
12.93 | 2903605 |
MESH:D013742 |
Tetanus |
|
Propofol |
12.93 | 2903605 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.60 | 10850423 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.54 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.62 | 6587162 6582329 7505956 1399818 3712494 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.32 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
4.09 | 16543248 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.87 | 17262798 |
MESH:D014202 |
Tremor |
|
Pilocarpine |
5.44 | 17594079 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.17 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.61 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
4.61 | 11723127 17306315 16452187 16712894 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.30 | 8888407 |
MESH:D014570 |
Urologic Diseases |
|
Diazinon |
4.92 | 16487989 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.46 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
4.00 | 12562636 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.07 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.23 | 12125929 |
MESH:D019043 |
Vascular Neoplasms |
|
Urethane |
5.55 | 10620525 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.89 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
8.84 | 16141801 20107430 20564506 17502770 20521320 16402076 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
8.84 | 16723640 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
4.72 | 17933447 |